Project Grant R21AI182816
Award Date
6/25/25
Completion Date
5/31/27
Dollars Obligated
$423K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training (CFDA 93.859) federal grant program, provides $392,500.00 to Arizona State University (ASU) to conduct research on predictive models for cross-species viral transmission from wild mammals to humans. The key objectives are to: 1) develop automated tools for curating mammal and virus genetic data to update taxonomic classifications and phylogenies, 2) test...
This Project Grant award, valued at $792,687.00 and issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to define the structural features of sialoglycans necessary for influenza A virus (IAV) infection and adaptation across various host species. The key activities under this award include: 1) using CRISPR/Cas9 techniques to truncate different types of sialoglycans in human lung...
This federal Project Grant award, totaling $711,555.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The overarching goal of this 5-year project, awarded on May 13, 2025 and running through April 30, 2030, is to contribute to the fundamental understanding of the spatiotemporal transmission dynamics and control of vaccine-preventable childhood infections. The project aims to develop...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will provide $2,065,600.00 to investigate the paradox of non-reciprocal flavivirus immunity. The grant, awarded on July 24, 2024 with an ultimate completion date of May 31, 2029, will integrate studies in nonhuman primate models and human cohorts to evaluate the impact of flavivirus exposure on antibody repertoire...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to characterize human-animal contact networks and improve zoonotic disease modeling. The $720,456 award, with a performance period from September 2024 to August 2029, will be used to collect empirical data on human-livestock contact networks in Mongolia, develop generative network models, and integrate these...
This Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the dynamics and evolution of HIV Gag and GagPol processing. The $752,745 award aims to use molecular dynamics simulations, single-molecule FRET imaging, and cryo-electron tomography to probe the structure and dynamics of Gag and GagPol that enable ordered processing by the viral...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $397,135 to Colorado State University to evaluate the potential for zoonotic transmission and human infection by select simian immunodeficiency viruses (SIVs) using a humanized mouse model. The study aims to investigate the cell tropism, CD4 T cell depletion, and sexual transmission capacity of human-adapted SIV...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $220,224.00 to the University of Chicago to computationally investigate key morphological transitions in the HIV-1 life cycle. The research aims to improve understanding of the assembly and disassembly processes involved in HIV-1 infection, including virion budding, viral core maturation, and capsid uncoating. This...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $219,792 to the University of Wisconsin - Madison to develop statistical methods for analyzing high-throughput T-cell receptor sequencing (TCR-seq) data. The goal is to improve the ability to identify rare T-cell clonotypes and characterize the TCR repertoire, which provides critical insights into the immune system's response to disease. The...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $369,431 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Wisconsin-Eau Claire on August 21, 2024. The grant will support research to quantitatively describe the host-seeking behaviors of schistosome miracidia, the aquatic, snail-infective stage of parasitic flatworms that cause schistosomiasis. The project aims to extract behavioral fingerprints from...